David Klonoff, MD
|School||UCSF School of Medicine|
|Address||3333 California Street|
San Francisco CA 94104
|UC San Francisco||MD ||School of Medicine||1976|
|UCLA Hospital||Intern and Resident||Internal Medicine||1978|
|UC San Francisco||Resident||Internal Medicine||1979|
|UC San Francisco||Endocrinology Fellow||Metabolic Research Unit||1981|
||1971||Phi Beta Kappa (Junior Year)|
|UC San Francisco||
||1975||Alpha Omega Alpha (Junior Year)|
|American College of Physicians||
|Madras (India) Diabetes Research Foundation||
||2012||Gold Medal Oration Award|
|American Institute of Medical and Biological Engineering||
|Fellow of Royal College of Physicians of Edinburgh||
David C. Klonoff, M.D. is an endocrinologist specializing in diabetes technology. He is a Clinical Professor of Medicine at UCSF and the Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services in San Mateo, California. Dr. Klonoff received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. He has been cited as being in the top 1% of endocrinologists nationally by Castle Connolly Medical Ltd. In 2012 Dr. Klonoff was elected as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and cited as one of the 1000 top bioengineers in the world, as well as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology. He received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation of Chennai, India. Dr. Klonoff was invited to participate in the White House Health and Cybersecurity Roundtable in 2015. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology. He has authored over 230 publications. Dr. Klonoff founded the Diabetes Technology Meeting, the Clinical Diabetes Technology Meeting, the International Hospital Diabetes Meeting, and MEDSec – the Medical Device Cybersecurity and Privacy Meeting. He was the lead investigator for the first randomized controlled multicenter trial of an outpatient closed loop control product, and published the results in the New England Journal of Medicine. Dr. Klonoff chaired the scientific advisory board for the first FDA-cleared insulin patch pump and participated in developing the first FDA-cleared dedicated diabetes telemedicine system and the two FDA-approved inhaled insulins. He has been an advisor to Google for their smart contact lens project. Dr. Klonoff has chaired or served on grant review panels for NIH, CDC, NASA, NSF, US Army, ADA, and JDRF. Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals. He was a member of the NIH Diabetes Interagency Coordinating Committee, whose ten-year research plan was released in 2011. Dr. Klonoff chaired the Endocrine Society Task Force on CGM Clinical Guidelines, the CLSI Subcommittee on CGM Metrics (POCT5), and the Diabetes Technology Society/FDA/Endocrine Society/ADA/AAMI Error Grid Panel. Dr. Klonoff currently chairs the Surveillance of FDA-Cleared Blood Glucose Monitors Program and DTSec (DTS Cybersecurity Standard for Connected Diabetes Devices Program), which was featured in Wired Magazine in 2015. He is a member of the NSBRI Board of Scientific Counselors and the NASA Exploration Medical Capabilities Standing Review Panel.
PRESENT ACADEMIC AND PROFESSIONAL POSITION
2006-Present Editor-in-Chief, Journal of Diabetes Science and Technology
2000-Present Medical Director, Dorothy L. and James E. Frank Diabetes Research Institute,
Mills-Peninsula Health Services, San Mateo, California
1995-Present Clinical Professor, Department of Medicine, U.C. San Francisco
1972-1976 University of California at San Francisco: M.D.
1968-1972 University of California at Berkeley: B.S. in Genetics (with Highest Honors)
Diabetes, diabetes technology, bioengineering, cybersecurity, and endocrinology.
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.